Novo Nordisk Seeks to Revolutionize Weight Loss with Daily Pill Form Wegovy
In a significant breakthrough, Novo Nordisk has announced that its weight-loss medication Wegovy is now available in pill form, marking the first GLP-1 weight-loss medication to transition away from weekly injections. This development is expected to make it easier for individuals to incorporate weight loss into their daily routine.
The new pill form of Wegovy contains the same active ingredient as Ozempic and has been shown to promote significant weight loss and reduce the risk of cardiovascular events in adults who are overweight or obese. The medication works by mimicking a hormone produced by the small intestine, which helps to lower blood sugar levels and slow digestion.
To use the new pill form of Wegovy, patients must take it daily on an empty stomach with a small amount of water. They are also instructed not to eat, drink, or take other medications for 30 minutes after taking the pill. The starter dose is available in pharmacies with a prescription, with stronger doses expected by the end of the week.
According to Ed Cinca, senior vice president for marketing and patient solutions at Novo Nordisk, the pill form will enable more people to achieve their weight loss goals and reduce the risks associated with cardiovascular disease. "We know there are people who are interested in addressing their weight but have been waiting on the sidelines for a medicine that was right for them," he said. "For many of them, that wait is over."
In terms of affordability, commercially-insured individuals may pay as little as $25 per month for the pill under Novo Nordisk's savings program. Those paying out of pocket will face a monthly cost of $149 for the 1.5 mg and 4 mg doses until April 15, when the dose increases to $199.
The FDA approved the pill form after a 64-week trial involving 307 adults who were overweight or obese but did not have diabetes. The results showed that those taking the 25 mg dose lost an average of 17% of their body weight and experienced reduced cardiovascular risk.
While similar medications are also available in injection form, Eli Lilly is seeking to bring its own pill form, forglipron, to market by this summer. Preliminary results from clinical trials have been promising, with an average weight loss of 11% over 72 weeks on the highest dose.
The introduction of the Wegovy pill marks a significant shift in the way people approach weight loss, making it easier and more accessible for individuals to take control of their health.
In a significant breakthrough, Novo Nordisk has announced that its weight-loss medication Wegovy is now available in pill form, marking the first GLP-1 weight-loss medication to transition away from weekly injections. This development is expected to make it easier for individuals to incorporate weight loss into their daily routine.
The new pill form of Wegovy contains the same active ingredient as Ozempic and has been shown to promote significant weight loss and reduce the risk of cardiovascular events in adults who are overweight or obese. The medication works by mimicking a hormone produced by the small intestine, which helps to lower blood sugar levels and slow digestion.
To use the new pill form of Wegovy, patients must take it daily on an empty stomach with a small amount of water. They are also instructed not to eat, drink, or take other medications for 30 minutes after taking the pill. The starter dose is available in pharmacies with a prescription, with stronger doses expected by the end of the week.
According to Ed Cinca, senior vice president for marketing and patient solutions at Novo Nordisk, the pill form will enable more people to achieve their weight loss goals and reduce the risks associated with cardiovascular disease. "We know there are people who are interested in addressing their weight but have been waiting on the sidelines for a medicine that was right for them," he said. "For many of them, that wait is over."
In terms of affordability, commercially-insured individuals may pay as little as $25 per month for the pill under Novo Nordisk's savings program. Those paying out of pocket will face a monthly cost of $149 for the 1.5 mg and 4 mg doses until April 15, when the dose increases to $199.
The FDA approved the pill form after a 64-week trial involving 307 adults who were overweight or obese but did not have diabetes. The results showed that those taking the 25 mg dose lost an average of 17% of their body weight and experienced reduced cardiovascular risk.
While similar medications are also available in injection form, Eli Lilly is seeking to bring its own pill form, forglipron, to market by this summer. Preliminary results from clinical trials have been promising, with an average weight loss of 11% over 72 weeks on the highest dose.
The introduction of the Wegovy pill marks a significant shift in the way people approach weight loss, making it easier and more accessible for individuals to take control of their health.
The fact that Novo Nordisk is pushing this pill form of Wegovy makes total sense, considering how inconvenient weekly injections can be 
. Now we can just pop a pill in the morning and forget about it until dinner time 
! It's awesome to see pharmaceutical companies working on making weight loss more accessible, especially with prices that won't break the bank 
$25/month for those with insurance is a steal! But I'm still worried about people taking this pill without consulting their doctor first 
can imagine having a daily routine that actually helps u shed those extra pounds 
also, the fact that it's affordable for commercially-insured individuals is a major win $25 a month? that's like a breath of fresh air 
my only concern is that people might not be aware of how to take it properly so we need to make sure ppl are getting the right info 
Those commercial insurance folks are gonna be able to get it for like $25/month which is pretty sweet, but out-of-pocket payers are gonna be stuck at $149/month. That's not exactly cheap. I guess it's good that they're making it more accessible, but we need to make sure everyone can afford the meds no matter what their situation 
just think about how many ppl got frustrated with weekly injections 
can't imagine having to do that every week... now they can just pop a pill and be done with it 
25 bucks a month is crazy affordable for insures, but still way out of reach for others 
the pill form is defo gonna change the game 
, i mean we all know how hard it is to stick to an injection schedule lol. but seriously, $25 a month for commercial insures is lowkey amazing 
. gotta say, 17% weight loss in 64 weeks is no joke 
. No more weekly injections or having to deal with needles, yay! 
. Can't wait to see the impact this has on people's lives! 
can't wait to see how this changes the weight loss scene and makes it easier for people to achieve their goals 
. And the prices are pretty reasonable too - $25 a month for commercially-insured ppl? That's like a drop of water compared to what some people pay out of pocket. 
! I've seen so many ppl struggle with injections, and now it's finally happening 
. And the prices? 
and I'm super stoked! It's like, finally some good news for all the people struggling with weight loss 
. It's about time! 
just give us the pill form already! its like 1mg who needs that much stress? $25 a month is still kinda steep tho 
but $149 is still pretty steep 4 most people 
I'm literally so hyped about this new pill form of Wegovy!!! 
I've been trying to get into this whole fitness thing but it's hard when you're just starting out and don't know where to begin. This pill form makes sense though, I mean who has time to give themselves injections every week? 
So yeah I think this is a game changer for people who are struggling with their weight. But now I'm curious about how it works... like does it really help you feel full or something? 
what about people with food allergies or intolerances? won't they be able to take this pill without having a reaction? and how is 30 minutes of no eating or drinking supposed to work in real life? seems kinda unrealistic 